Translating ASCO 2026: What Matters Most for Managed Care
By Richa Madurkar, PharmD, BCOP, Senior Lead Clinical Pharmacist at OncoHealth Key Takeaways Novel oncology drugs and new treatment pathways presented at ASCO are positioned to change the treatment landscape across several different types of cancer Payors need to be...
Webinar: Translating ASCO 2026: What Matters Most for Managed Care
Innovations in Bladder Cancer Therapy: Implications for Managed Care
Authors: Adam Leikensohn, MD & Richa Madurkar, PharmD, BCOP The treatment landscape for bladder cancer is rapidly evolving. Additional therapeutic options have been recently approved or are in the pipeline for patients in both non-muscle invasive and...